Current Pharmacogenomics and Personalized Medicine
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 2
Author(s): Ari Hirvonen*
Affiliation:
- Adjunct Professor of Molecular Genetics University of Helsinki Helsinki,Finland
Export Options
About this article
Cite this article as:
Hirvonen Ari*, Meet Our Editorial Board Member, Current Pharmacogenomics and Personalized Medicine 2016; 14 (2) . https://dx.doi.org/10.2174/187569211402170424204837
DOI https://dx.doi.org/10.2174/187569211402170424204837 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Melatonin Role in Experimental Arthritis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Clinically Relevant Genetic Variations in Drug Metabolizing Enzymes
Current Drug Metabolism Do Epigenetic Pathways Initiate Late Onset Alzheimer Disease (LOAD): Towards a New Paradigm
Current Alzheimer Research Editorial [Hot Topic: Adenosine-Based Modulation of Brain Activity (Guest Editor: DETLEV BOISON)]
Current Neuropharmacology Recent Insights on the Medicinal Chemistry of Metal-Based Compounds: Hints for the Successful Drug Design
Current Medicinal Chemistry Triazene Compounds in the Treatment of Acute Myeloid Leukemia: A Short Review and a Case Report
Current Medicinal Chemistry New Trends in the Development of Oral Antidiabetic Drugs
Current Medicinal Chemistry Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril: An In silico Study
Central Nervous System Agents in Medicinal Chemistry Analysis of Glycosylation and Other Post-Translational Modifications by Mass Spectrometry
Current Analytical Chemistry Lung Cancer Epidemiology - A Global View
Current Respiratory Medicine Reviews Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders
Current Pharmaceutical Design Electrochemical Evaluation of an Outdated Antifungal Drug as Corrosion Inhibitor of Mild Steel in Neutral Chloride Media
Innovations in Corrosion and Materials Science (Discontinued) <i>In Vivo/Ex Vivo</i> EPR Investigation of the Brain Redox Status and Blood-Brain Barrier Integrity in the 5xFAD Mouse Model of Alzheimer's Disease
Current Alzheimer Research Basic Pharmacology of NMDA Receptors
Current Pharmaceutical Design TRP Channels: New Potential Therapeutic Approaches in CNS Neuropathies
CNS & Neurological Disorders - Drug Targets Is Intraoperative Opioids Avoidance A Utopia? A Matched Study in Laparoscopic Hysterectomy
Current Reviews in Clinical and Experimental Pharmacology Analgesic and Antineuropathic Drugs Acting Through Central Cholinergic Mechanisms
Recent Patents on CNS Drug Discovery (Discontinued) From Small to Big Molecules: How Do We Prevent and Delay the Progression of Age-Related Neurodegeneration?
Current Pharmaceutical Design Resurrecting Clinical Pharmacology As a Context for Alzheimer Disease Drug Development
Current Alzheimer Research Electroencephalography and Dementia: A Literature Review and Future Perspectives
CNS & Neurological Disorders - Drug Targets